Genomics BioSci & Tech. Co.,Ltd.

NT$14.40As of Sun 8 Nov 2026, 12:00 UTC
TWSE:4195Healthcare
Country Taiwan
PE (Fwd) •••
TSR 10Y CAGR (0.87%)
Div yield —
ROE (8.33%)
Biological Products, Except Diagnostic Substances
Beta (5Y) (0.10)
PE TTM —
TSR TTM (45.66%)
Mkt cap NT$1.152B
ROIC (11.99%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
NT$17
19.22%
(45.49%)
Hold 8|12|9|0|1
4Q25
1Q26
2Q26
3Q26
Earnings per shareNT$
0.16
0.17
0.18
0.18
0.41%
8.90%
9.61%
10.91%
RevenueNT$M
71.30
71.38
71.66
75.66
6.86%
8.87%
4.78%
7.10%
Peers (US$34.79M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
0.076
(0.115)
(0.094)
EBIT/Intx
1.655
1.115
1.022
Own earn%
30.78
41.24
56.90
Sh yield%
23.86
54.57
55.78
Owners
Insiders/Inst%
8.00
22.16
Short interest%
2.56
SBC / revenue%
5.54
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
0
Op margin range%
17–24
$1 testx
—
Incr. ROIC%
9